Lawrence Steinman, Director at BioAtla, Inc. (BCAB), sold 450 shares at $40.60 ($18K) on 2021-08-16, disclosed to the SEC on 2021-08-18.
Scheduled sale ($18k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KTTA | BUY | 2023-06-06 | $13K | — | Filing → |
| ATNF | BUY | 2023-06-02 | $22K | — | Filing → |
| ATNF | BUY | 2021-12-10 | $21K | — | Filing → |